Research Repository

Teolmerase activity in plueral malignant mesotheliomas

Au, Amy and Hackl, Torben and Yeager, Thomas and Cohen, Scott and Pass, Harvey and Harris, Curtis and Reddel, Roger (2011) Teolmerase activity in plueral malignant mesotheliomas. Lung cancer, 73 (3). pp. 283-288. ISSN 0169-5002 (print) 1872-8332 (online)

Full text for this resource is not available from the Research Repository.

Abstract

New treatments are needed for malignant pleural mesothelioma (MPM), which currently has a poor prognosis. Cellular immortalisation, one of the hallmarks of cancer, depends on the activity of a telomere length maintenance mechanism (TMM) – either telomerase or alternative lengthening of telomeres (ALT). The TMMs are widely regarded as potential targets for cancer therapies and telomerase inhibitors have entered clinical trials. The aim of this study was to determine what proportion of MPMs use ALT and/or telomerase. Forty-three MPMs from 42 patients were examined for telomerase and ALT activity. Telomerase activity was detected by immunoaffinity purification followed by the telomere repeat amplification protocol (TRAP), and ALT activity was determined by the C-circle assay and by assessing telomere lengths using terminal restriction fragment analyses. We found that 43 of 43 MPMs were telomerase-positive[+] and ALT-negative[−]. Therefore, to investigate whether pleural mesothelial cells are unusually susceptible to activation of telomerase, we examined activation of the TMMs in an in vitro model of cellular immortalisation, in which normal pleural mesothelial cells were transduced with simian virus 40 (SV40) oncogenes. We found that normal mesothelial cells were TMM-negative, and that expression of the SV40 oncogenes did not directly activate telomerase or ALT. Immortalisation, which in this experimental system results from additional genetic changes that have not yet been identified, was accompanied by activation of either TMM. Therefore, pleural mesothelial cells are capable of activating either TMM in vitro, and the observation that 100% of MPMs were telomerase[+] suggests that there are factors in vivo that select for telomerase activity during oncogenesis of this tumour type. We conclude that MPM is a tumour that could be considered for anti-telomerase therapy.

Item Type: Article
Uncontrolled Keywords: ResPubID22791. malignant mesothelioma, telomerase, alternative lengthening of telomeres, immortalisation, telomere maintenance mechanism, pleura
Subjects: Faculty/School/Research Centre/Department > School of Engineering and Science
FOR Classification > 0601 Biochemistry and Cell Biology
SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions)
Depositing User: VUIR
Date Deposited: 21 May 2012 07:01
Last Modified: 21 May 2012 07:01
URI: http://vuir.vu.edu.au/id/eprint/7871
ePrint Statistics: View download statistics for this item

Repository staff only

View Item View Item

Search Google Scholar